Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis

被引:10
|
作者
Wybrecht, Delphine [1 ,2 ]
Reuter, Francoise [1 ,3 ]
Zaaraoui, Wafaa [1 ]
Faivre, Anthony [1 ,2 ]
Crespy, Lydie [1 ,3 ]
Rico, Audrey [1 ,3 ]
Malikova, Irina [1 ,3 ]
Confort-Gouny, Sylviane [1 ]
Soulier, Elisabeth [1 ]
Cozzone, Patrick J. [1 ]
Pelletier, Jean [1 ,3 ]
Ranjeva, Jean-Philippe [1 ]
Audoin, Bertrand [1 ,3 ]
机构
[1] Aix Marseille Univ, CEMEREM, UMR 7339, Marseille, France
[2] Hop Instruct Armees St Anne, Serv Neurol, F-83800 Toulon, France
[3] Hop Enfants La Timone, APHM, Serv Neurol, Marseille, France
关键词
multiple sclerosis; MRI; cognition; disability; prediction; CIS; CLINICALLY ISOLATED SYNDROMES; EARLY COGNITIVE IMPAIRMENT; 10-YEAR FOLLOW-UP; LESION LOCATION; CALLOSAL ATROPHY; BRAIN MRI; ABNORMALITIES; DEFICITS; ONSET;
D O I
10.1177/1352458512442991
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The ability of conventional magnetic resonance imaging (MRI) to predict subsequent physical disability and cognitive deterioration after a clinically isolated syndrome (CIS) is weak. Objectives: We aimed to investigate whether conventional MRI changes over 1 year could predict cognitive and physical disability 5 years later in CIS. We performed analyses using a global approach (T-2 lesion load, number of T-2 lesions), but also a topographic approach. Methods: This study included 38 patients with a CIS. At inclusion, 10 out of 38 patients fulfilled the 2010 revised McDonald's criteria for the diagnosis of multiple sclerosis. Expanded Disability Status Scale (EDSS) evaluation was performed at baseline, year 1 and year 5, and cognitive evaluation at baseline and year 5.T-2-weighted MRI was performed at baseline and year 1. We used voxelwise analysis to analyse the predictive value of lesions location for subsequent disability. Results: Using the global approach, no correlation was found between MRI and clinical data. The occurrence or growth of new lesions in the brainstem was correlated with EDSS changes over the 5 years of follow-up. The occurrence or growth of new lesions in cerebellum, thalami, corpus callosum and frontal lobes over 1 year was correlated with cognitive impairment at 5 years. Conclusion: The assessment of lesion location at the first stage of multiple sclerosis may be of value to predict future clinical disability.
引用
收藏
页码:1585 / 1591
页数:7
相关论文
共 50 条
  • [31] Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis
    Ciccarelli, O
    Giugni, E
    Paolillo, A
    Mainero, C
    Gasperini, C
    Bastianello, S
    Pozzilli, C
    EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) : 455 - 459
  • [32] Cognition in Early Relapsing-Remitting Multiple Sclerosis: Consequences May Be Relative to Working Memory
    Berrigan, Lindsay I.
    LeFevre, Jo-Anne
    Rees, Laura M.
    Berard, Jason
    Freedman, Mark S.
    Walker, Lisa A. S.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2013, 19 (08) : 938 - 949
  • [33] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
  • [34] Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis
    Lauerer, Markus
    McGinnis, Julian
    Bussas, Matthias
    El Husseini, Malek
    Pongratz, Viola
    Engl, Christina
    Wuschek, Alexander
    Berthele, Achim
    Riederer, Isabelle
    Kirschke, Jan S.
    Zimmer, Claus
    Hemmer, Bernhard
    Muehlau, Mark
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (01) : 37 - 43
  • [35] Self-Organizing Maps as a Tool for Segmentation of Magnetic Resonance Imaging (MRI) of Relapsing-Remitting Multiple Sclerosis
    Mei, Paulo Afonso
    Carneiro, Cleyton de Carvalho
    Kuroda, Michelle Chaves
    Fraser, Stephen J.
    Min, Li Li
    Reis, Fabiano
    2017 12TH INTERNATIONAL WORKSHOP ON SELF-ORGANIZING MAPS AND LEARNING VECTOR QUANTIZATION, CLUSTERING AND DATA VISUALIZATION (WSOM), 2017, : 43 - 49
  • [36] Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings
    Rinaldi, F.
    Seppi, D.
    Calabrese, M.
    Perini, P.
    Gallo, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1640 - 1643
  • [37] Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis
    Bonnet, Melissa C.
    Deloire, Mathilde S. A.
    Salort, Emmanuelle
    Dousset, Vincent
    Petry, Klaus G.
    Brochet, Bruno
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 251 (1-2) : 23 - 28
  • [38] Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Tizio, Santiago
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2012, 70 (08) : 574 - 577
  • [39] No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability
    Martin Juenemann
    Mesut Yeniguen
    Erwin Stolz
    Martin Berghoff
    Journal of Neurology, 2013, 260 : 2409 - 2410
  • [40] Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis
    Hartung, Hans-Peter
    Benedict, Ralph H. B.
    Berger, Thomas
    Bermel, Robert A.
    Brochet, Bruno
    Carroll, William M.
    Freedman, Mark S.
    Holmoy, Trygve
    Karabudak, Rana
    Nos, Carlos
    Patti, Francesco
    Perrin Ross, Amy
    Vanopdenbosch, Ludo
    Vollmer, Timothy
    Wuerfel, Jens
    Clinch, Susanne
    Kadner, Karen
    Kuenzel, Thomas
    Kulyk, Inessa
    Raposo, Catarina
    Thanei, Gian-Andrea
    Killestein, Joep
    NEUROLOGY, 2024, 103 (12)